HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (3) Citing Articles via Google Scholar Google Scholar Articles by Davies, G. Articles by Wilson, R. Search for Related Content PubMed PubMed Citation Articles by Davies, G. Articles by Wilson, R.

The effect of Pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis

¹ Host Defence Unit, and ² Interstitial Lung Disease Unit, Royal Brompton Hospital, London, UK.

CORRESPONDENCE: R. Wilson, Royal Brompton Hospital, Sydney Street, London SW3 6NP, UK. Fax: 44 2073518338. E-mail: r.wilson{at}rbht.nhs.uk

Keywords: Bronchiectasis, Pseudomonas aeruginosa, pulmonary function

Received: June 27, 2005
Accepted July 31, 2006

Bronchiectasis patients are susceptible to infection with Pseudomonas aeruginosa. Isolation is associated with increased severity of disease, greater airflow obstruction and poorer quality of life. It is not known whether infection by P. aeruginosa is a marker of disease severity or contributes to disease progression.

Consecutive non-cystic fibrosis adult bronchiectasis outpatients (n = 163) with multiple sputum cultures and follow-up pulmonary function tests were designated, according to isolation of P. aeruginosa, as "never infected" (group 1; n = 67), "intermittently isolated" (group 2; n = 82) and "chronically infected" (group 3; n = 14). Based upon change in forced expiratory volume in one second (FEV₁) % predicted levels at 2 yrs after presentation, longitudinal behaviour was characterised as "improvement" (10% rise), "decline" (10% fall) or "stability". Baseline pulmonary-function tests and longitudinal behaviour were examined in relation to pseudomonas status.

There was no difference between the groups in age, sex, smoking habit or length of follow-up. Baseline FEV₁ levels were highest in group 1 (mean±SD: 77.4±24.3) and higher in group 2 (67.3±25.7) than in group 3 (55.2±18.5). The same significant trends were seen for baseline FEV₁/forced vital capacity ratios and diffusing capacity of the lung for carbon monoxide levels. Subsequent longitudinal behaviour was linked to baseline FEV₁ levels, which were lowest in patients with improvement and lower in association with decline than with stability. However, longitudinal behaviour did not differ between groups 1, 2 and 3, either before or after adjustment for baseline FEV₁ levels.

Infection by Pseudomonas aeruginosa occurs in bronchiectasis patients with more severe impairment of pulmonary function but does not influence rate of decline in pulmonary function either before or after adjustment for baseline disease severity. Thus, Pseudomonas aeruginosa is a marker of bronchiectasis severity but is not linked to an accelerated decline in pulmonary function.

This article has been cited by other articles:

				M. A. Martinez-Garcia, J.-J. Soler-Cataluna, M. Perpina-Tordera, P. Roman-Sanchez, and J. Soriano Factors Associated With Lung Function Decline in Adult Patients With Stable Non-Cystic Fibrosis Bronchiectasis Chest, November 1, 2007; 132(5): 1565 - 1572. [Abstract] [Full Text] [PDF]